Get 20% lifetime commission for referring investors to digrin.com
here.
TRACON Pharmaceuticals, Inc. ( TCON) - Key Metrics
Stock symbol TCON is outdated, potentially delisted? Maybe it is available on other exchange?
TCON Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.02 | -$0.94 | -$0.92 | -$0.92 |
| 2024Q1 | $0.04 | -$1.33 | -$1.07 | -$1.07 |
| 2023Q4 | $1.24 | $0.18 | -$0.21 | -$0.21 |
| 2023Q3 | ? | $5.80 | $8.11 | $8.11 |
| 2023Q2 | $5.85 | -$4.09 | -$3.80 | -$3.80 |
TCON Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -0.29 |
| 2024Q1 | ? | -1.55 |
| 2023Q4 | ? | 4.91 |
| 2023Q3 | ? | 0.15 |
| 2023Q2 | ? | -0.36 |
TCON Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q2 | -82.93% | ? |
| 2024Q1 | -12.97% | ? |
| 2023Q4 | -6.05% | ? |
| 2023Q3 | 227.84% | ? |
| 2023Q2 | -65.34% | ? |
TCON
Price: $0.03
52 week price:
Earnings Per Share: 5.93 USD
P/E Ratio: 0.01
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 47100
Ebitda: 1.4 millionMarket Capitalization: 109725